For nearly four decades, cancer researchers faced a persistent problem. They knew that a mutation in a gene called KRAS was driving some of the deadliest tumors for pancreatic, lung, and colorectal cancers, but every attempt to build a drug that could block it came up short.
Similar Posts
How the Expiration of ACA Tax Credits Will Impact Commercial Insurance, Per a Cigna Exec
The government shutdown is still underway, and a key sticking point of this shutdown is the…
Managing Pre-Diabetes: The Link Between Diabetes and Weight Loss
Spread the love Understanding Pre-Diabetes Pre-diabetes is a health condition marked by elevated blood sugar levels…
Dry Skin? You Must Try This Simple Tip From A Cosmetic Chemist
There are seemingly endless ways to switch up your skin care routine. Every time I talk…
Classic Pumpkin Pie
I used to always get so frazzled when it was time to make the annual pumpkin…
Who Needs Humans, Anyway? – The Health Care Blog
By KIM BELLARD Imagine my excitement when I saw the headline: “Robot doctors at world’s first…
Flaky Oven-Baked Salmon (Cooked in Foil!)
Bland, dry salmon no more! My parents made salmon all the time growing up and they…
